Accessibility Menu

Sanai Health Industry Group(FRA) WUP

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
N/A

Sanai Health Industry Group Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

WUP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sanai Health Industry Group

Sanai Health Industry Group Co. Ltd. is an investment holding company, which through its subsidiaries, engages in developing, manufacturing, marketing, and sales of pharmaceutical products. It operates through the following segments: Pharmaceutical Products, Finance Leasing, Other General Trading, and Genetic Testing and Molecular Diagnostic Services. The Pharmaceutical Products segment engages in development, manufacturing, marketing and sales of pharmaceutical products and sales of health care products. The Finance Leasing segment engages in provision of finance leasing services. The Other General Trading segment engages in trading of goods other than pharmaceutical products. The Genetic Testing and Molecular Diagnostic Services segment engages in provision of genetic testing and molecular diagnostic services. The firm focuses on therapeutic drugs for respiratory, cardiovascular, and gastrointestinal diseases, as well as parenteral nutrition, antibiotics, antiviral, and antifungal products. The company was founded on March 21, 2006 and is headquartered in Hong Kong.

Industry

Pharmaceuticals

Employees

160

CEO

Ou Wen Lin

WUP Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Sanai Health Industry Group Performance Analysis

Sanai Health Industry Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 24,858,554180.3%
20232023-12-31USD 14,069,025-43.4%
20242024-12-31USD 10,946,685-22.2%
20252025-12-31USD 10,588,306-3.3%
Sanai Health Industry Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.03197.9%
20232023-12-31USD 0.02-44.1%
20242024-12-31USD -0.01N/A
20252025-12-31USD -0.0263.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About WUP

What is the current price of Sanai Health Industry Group?

Sanai Health Industry Group is trading at N/A per share.

What is the 52-week range for Sanai Health Industry Group?

Over the past 52 weeks, Sanai Health Industry Group has traded between N/A and N/A.

How much debt does Sanai Health Industry Group have?

As of the most recent reporting period, Sanai Health Industry Group reported total debt of $5.37M.

How much cash does Sanai Health Industry Group have on hand?

Sanai Health Industry Group reported $36.38M in cash and cash equivalents in its most recent financial results.

What is Sanai Health Industry Group’s dividend yield?

Sanai Health Industry Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.